• Filing Date: 2020-08-04
  • Form Type: 10-Q
  • Description: Quarterly report
v3.20.2
Segment Information (Summary of Operations by Segment) (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
customer
Jun. 30, 2019
USD ($)
customer
Jun. 30, 2020
USD ($)
customer
Jun. 30, 2019
USD ($)
customer
Dec. 31, 2019
customer
Segment Reporting Information [Line Items]          
NET REVENUE $ 10,038 $ 10,855 $ 24,573 $ 23,745  
COST OF GOODS SOLD, EXCLUDING DEPRECIATION AND AMORTIZATION (1,485) (1,174) (3,412) (2,774)  
GROSS PROFIT 8,553 9,681 21,161 20,971  
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 1,810 2,834 4,693 5,561  
GENERAL AND ADMINISTRATIVE EXPENSES 2,975 3,675 6,156 7,068  
SALES AND MARKETING EXPENSES 4,382 6,108 10,054 12,021  
DEPRECIATION AND AMORTIZATION 685 654 1,339 1,306  
OPERATING EXPENSES 9,852 13,271 22,242 25,956  
NET LOSS FROM OPERATIONS (1,299) (3,590) (1,081) (4,985)  
OTHER INCOME AND EXPENSES, NET (1,242) (1,187) (2,615) (2,484)  
NET LOSS BEFORE TAXES (2,541) (4,777) (3,696) (7,469)  
United States Segment          
Segment Reporting Information [Line Items]          
NET REVENUE 3,420 7,320 10,487 14,086  
COST OF GOODS SOLD, EXCLUDING DEPRECIATION AND AMORTIZATION (423) (808) (1,182) (1,493)  
GROSS PROFIT 2,997 6,512 9,305 12,593  
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 1,098 1,630 3,020 3,057  
GENERAL AND ADMINISTRATIVE EXPENSES 1,943 2,150 3,915 4,084  
SALES AND MARKETING EXPENSES 3,207 4,217 7,487 8,258  
OPERATING EXPENSES 6,248 7,997 14,422 15,399  
NET LOSS FROM OPERATIONS $ (3,251) $ (1,485) $ (5,117) $ (2,806)  
United States Segment | Customer Concentration Risk | Revenues          
Segment Reporting Information [Line Items]          
Number of customers | customer 2 2 2 2  
Concentration risk percentage 34.00% 67.00% 43.00% 59.00%  
United States Segment | Customer Concentration Risk | Accounts Receivable          
Segment Reporting Information [Line Items]          
Number of customers | customer     2   2
Concentration risk percentage     55.00%   68.00%
International Segment          
Segment Reporting Information [Line Items]          
NET REVENUE $ 6,618 $ 3,535 $ 14,086 $ 9,659  
COST OF GOODS SOLD, EXCLUDING DEPRECIATION AND AMORTIZATION (1,062) (366) (2,230) (1,281)  
GROSS PROFIT 5,556 3,169 11,856 8,378  
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 664 1,090 1,557 2,261  
GENERAL AND ADMINISTRATIVE EXPENSES 838 946 1,775 1,933  
SALES AND MARKETING EXPENSES 1,100 1,779 2,392 3,484  
OPERATING EXPENSES 2,602 3,815 5,724 7,678  
NET LOSS FROM OPERATIONS 2,954 (646) 6,132 700  
Other Segments          
Segment Reporting Information [Line Items]          
RESEARCH, DEVELOPMENT AND MEDICAL AFFAIRS EXPENSES 48 114 116 243  
GENERAL AND ADMINISTRATIVE EXPENSES 194 579 466 1,051  
SALES AND MARKETING EXPENSES 75 112 175 279  
DEPRECIATION AND AMORTIZATION 685 654 1,339 1,306  
OPERATING EXPENSES 1,002 1,459 2,096 2,879  
NET LOSS FROM OPERATIONS (1,002) (1,459) (2,096) (2,879)  
OTHER INCOME AND EXPENSES, NET $ (1,242) $ (1,187) $ (2,615) $ (2,484)